<!DOCTYPE html>
<html>
  <head>
    <title>Heart failure</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/cardiovascular/">cardiovascular</a></li>
      <li><a href="/notes/cardiovascular/cardiovasulcar risk management/">cardiovasulcar risk management</a></li>
      <li class="active">Heart failure</li>
  </ol>

  <div class="page-header">
 
    <h1>Heart failure</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Heart failure</strong></a>
          <div class="toc">
<ul>
<li><a href="#symptoms">Symptoms</a><ul>
<li><a href="#typical">Typical</a></li>
<li><a href="#less-typical">Less typical</a></li>
</ul>
</li>
<li><a href="#signs">signs</a></li>
<li><a href="#heart-failure-with-preserved-ejection-fraction">Heart failure with preserved ejection fraction</a></li>
<li><a href="#heart-failure-with-reduced-ejection-fraction">Heart failure with reduced ejection fraction</a></li>
<li><a href="#investigations">Investigations</a><ul>
<li><a href="#mice-rule">MICE rule:</a></li>
<li><a href="#echo">ECHO</a></li>
<li><a href="#bnp">BNP</a></li>
<li><a href="#ecg">ECG</a></li>
<li><a href="#cxr">CXR</a></li>
</ul>
</li>
<li><a href="#classification">Classification</a></li>
<li><a href="#management">Management</a><ul>
<li><a href="#hf-ref">HF-REF</a></li>
<li><a href="#hf-pef">HF-PEF</a></li>
<li><a href="#non-pharmacological">Non-pharmacological</a></li>
<li><a href="#referral">Referral</a></li>
<li><a href="#left-ventricular-systolic-dysfunction">Left ventricular systolic dysfunction</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>Heart failure with reduced ejection fraction</p>
<p>heart failure with preserved ejection fraction</p>
</blockquote>
<ul>
<li>
<p>mortality:</p>
<ul>
<li>
<p>in first year after diagnosis 30-40% die; 10% per year thereafter</p>
</li>
<li>
<p>highest</p>
<ul>
<li>
<p>heart failure associated with:</p>
<ul>
<li>
<p>Acute MI</p>
</li>
<li>
<p>arrhythmia</p>
</li>
<li>
<p>hypotensive</p>
</li>
<li>
<p>NYHA class IV</p>
</li>
<li>
<p>repeated hospitalisation</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>M>F</p>
<ul>
<li>
<p>but F:</p>
<ul>
<li>
<p>older than males when develop heart failure</p>
</li>
<li>
<p>have heart failure with a preserved ejection fraction</p>
</li>
<li>
<p>live longer than males with heart failure</p>
</li>
<li>
<p>more pronounced symptoms of heart failure compared to males</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<blockquote>
<p>abnormality of structure or function of heart that leads to a failure of the heart to deliver sufficient oxygen to the metabolising tissues (or when heart can only do so with elevated diastolic filling pressures)</p>
<p>compensatory mechanisms eventually fail:</p>
<ul>
<li>
<p>increase HR</p>
</li>
<li>
<p>increase cardiac muslce mass</p>
</li>
<li>
<p>increase cardiac filling pressures and blood volume</p>
</li>
</ul>
</blockquote>
<ul>
<li>
<p>complex clincila syndrome</p>
<ul>
<li>typical signs and symptoms</li>
</ul>
</li>
<li>
<p>risk factos:</p>
<ul>
<li>
<p>IHD</p>
<ul>
<li>LV dysfunction</li>
</ul>
</li>
<li>
<p>HTN</p>
<ul>
<li>75% with heart failure</li>
</ul>
</li>
<li>
<p>Valvular heart disease</p>
</li>
<li>
<p>Rhythm/conduction AbN</p>
</li>
<li>
<p>Cardiomyopathy</p>
</li>
<li>
<p>DM</p>
</li>
<li>
<p>Male</p>
</li>
<li>
<p>excessive Etoh</p>
<ul>
<li>
<p>increase CVRA</p>
</li>
<li>
<p>direct cardiotoxin</p>
</li>
</ul>
</li>
<li>
<p>Smoking</p>
<ul>
<li>direct cardiotoxin</li>
</ul>
</li>
<li>
<p>Obesity</p>
</li>
<li>
<p>Dyslipidaemia</p>
</li>
<li>
<p>Respiratory condition</p>
</li>
<li>
<p>Thyroid disorders</p>
</li>
<li>
<p>Medicines</p>
</li>
<li>
<p>Cardiotoxins</p>
</li>
<li>
<p>Infections/inflammation</p>
</li>
<li>
<p>Congenital heart disease</p>
</li>
</ul>
</li>
<li>
<p>evaluation undertaken:</p>
<ul>
<li>
<p>new onset SOBOE</p>
</li>
<li>
<p>orthopnoea</p>
</li>
<li>
<p>PND</p>
</li>
<li>
<p>unless non cardiac cause</p>
</li>
</ul>
</li>
</ul>
<h3 id="symptoms">Symptoms</h3>
<h4 id="typical">Typical</h4>
<ul>
<li>
<p>dyspnoea</p>
</li>
<li>
<p>orthopnoea</p>
</li>
<li>
<p>PND</p>
</li>
<li>
<p>reduced exercise tolerance</p>
</li>
<li>
<p>Fatigue, weakness, more time needed to recover oafter exercise</p>
</li>
<li>
<p>ankle oedema</p>
<ul>
<li>
<p>consider varicose veins</p>
</li>
<li>
<p>medicines: CCB</p>
</li>
<li>
<p>decrease mobility</p>
</li>
</ul>
</li>
</ul>
<h4 id="less-typical">Less typical</h4>
<ul>
<li>
<p>nocturnal cough</p>
</li>
<li>
<p>wheezing</p>
</li>
<li>
<p>Weight gain of >2kg</p>
</li>
<li>
<p>bloated feeling</p>
</li>
<li>
<p>anorexia, nausea</p>
</li>
<li>
<p>cerrebral symptoms</p>
<ul>
<li>reduced cardiac output</li>
</ul>
</li>
<li>
<p>depression</p>
</li>
<li>
<p>palpitations, chest pain or pressure</p>
</li>
<li>
<p>syncope</p>
</li>
</ul>
<h3 id="signs">signs</h3>
<ul>
<li>
<p>more specific </p>
<ul>
<li>
<p>elevated JVP</p>
</li>
<li>
<p>prolonged hepatojugular reflex</p>
</li>
<li>
<p>third heart sound (gallop rhythm)</p>
</li>
<li>
<p>laterally displaced apicle impulse</p>
</li>
<li>
<p>cardiac murmur</p>
</li>
</ul>
</li>
<li>
<p>less specific</p>
<ul>
<li>
<p>peripheral oedema</p>
</li>
<li>
<p>crepitations</p>
</li>
<li>
<p>decrease AE (pleural effusion)</p>
</li>
<li>
<p>tachycardia</p>
</li>
<li>
<p>irregular pulse</p>
</li>
<li>
<p>Tachypnoea</p>
</li>
<li>
<p>Hepatomegaly</p>
</li>
<li>
<p>Cachexia</p>
</li>
</ul>
</li>
<li>
<p>careful attention causative factors:</p>
<ul>
<li>
<p>htn</p>
</li>
<li>
<p>MI</p>
</li>
<li>
<p>valvular heart disease</p>
</li>
<li>
<p>atrial fibrillation</p>
</li>
</ul>
</li>
<li>
<p>low specificity</p>
<ul>
<li>
<p>exertional SOB</p>
</li>
<li>
<p>ankle swelling</p>
</li>
</ul>
</li>
<li>
<p>more specific</p>
<ul>
<li>
<p>orthopnoea</p>
</li>
<li>
<p>PND</p>
</li>
</ul>
</li>
</ul>
<h3 id="heart-failure-with-preserved-ejection-fraction">Heart failure with preserved ejection fraction</h3>
<ul>
<li>
<p>50% of people with symptoms and signs of heart failure have been shown to have preserved or relatively preserved (≥ 45-50% LVEF)</p>
</li>
<li>
<p><strong>definition</strong></p>
<ul>
<li>
<p>Symptoms typical of heart failure</p>
</li>
<li>
<p>Signs typical of heart failure</p>
</li>
<li>
<p>Normal or only mildly red. LVEF and no LV dilatation</p>
</li>
<li>
<p>relevant structural heart disease:</p>
<ul>
<li>
<p>LV hypertrophy</p>
</li>
<li>
<p>LA enlargement</p>
</li>
<li>
<p>diastolic dysfunction</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>more frequently seen in:</p>
<ul>
<li>
<p>elderly</p>
</li>
<li>
<p>females</p>
</li>
<li>
<p>obese</p>
</li>
</ul>
</li>
<li>
<p>more likley to have</p>
<ul>
<li>
<p>AF</p>
</li>
<li>
<p>hypertension</p>
</li>
</ul>
</li>
<li>
<p>underlying causes;</p>
<ul>
<li>
<p>constrictive pericarditis</p>
</li>
<li>
<p>cardiomyotphay</p>
</li>
<li>
<p>hypertrophic cardiomyopahty</p>
</li>
<li>
<p>restrictive cardiomyopahty</p>
<ul>
<li>
<p>amyloidosis</p>
</li>
<li>
<p>sarcoidosis</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="heart-failure-with-reduced-ejection-fraction">Heart failure with reduced ejection fraction</h3>
<ul>
<li>
<p>impaired LV systolic function</p>
</li>
<li>
<p>definition</p>
<ul>
<li>
<p>typical symptoms and signs</p>
</li>
<li>
<p>evidence of reduced LVEF on ECHO</p>
</li>
</ul>
</li>
</ul>
<h3 id="investigations">Investigations</h3>
<h4 id="mice-rule">MICE rule:</h4>
<ul>
<li>
<p>increase diagnostic vaule of BNP and guide decisiions for ECHO</p>
</li>
<li>
<p><strong>M</strong>ale</p>
</li>
<li>
<p><strong>I</strong>nfarction</p>
</li>
<li>
<p><strong>C</strong>repitations</p>
</li>
<li>
<p><strong>E</strong>dema</p>
</li>
<li>
<p>symptomatic patients who have ≥1 of above</p>
<ul>
<li>
<p>refer for ECHO without need for BNP</p>
</li>
<li>
<p>else order BNP and refer based on above</p>
</li>
</ul>
</li>
<li>
<p>studies underway to validate use in primary care</p>
</li>
</ul>
<h4 id="echo">ECHO</h4>
<ul>
<li>
<p>gold standard</p>
</li>
<li>
<p>all patients should have ECHO</p>
</li>
<li>
<p>can get guidance from ECG and BNP</p>
<ul>
<li>
<p>2 weeks</p>
<ul>
<li>if history of previous MI and elevated BNP</li>
</ul>
</li>
<li>
<p>6 weeks</p>
<ul>
<li>if no history of MI and moderately raised BNP</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="bnp">BNP</h4>
<ul>
<li>
<p>assists in diagnosis</p>
</li>
<li>
<p>‘rule out’ test</p>
</li>
<li>
<p>cannot differentiate between HF-REF and HF-PEF</p>
</li>
<li>
<p>high levels associated with poorer prognosis</p>
</li>
<li>
<p>unlikely:</p>
<ul>
<li>\&lt;100</li>
</ul>
</li>
<li>
<p>likely </p>
<ul>
<li>>500</li>
</ul>
</li>
<li>
<p>grey zone</p>
</li>
<li>
<p>may be elevated in absence of HF:</p>
<ul>
<li>
<p>atrial fibrillation</p>
</li>
<li>
<p>COPD</p>
</li>
<li>
<p>ACS</p>
</li>
<li>
<p>pulmonary embolism</p>
</li>
<li>
<p>pulmonary hypertension</p>
</li>
<li>
<p>renal impairment</p>
</li>
</ul>
</li>
<li>
<p>may be normal/marginaly elevated:</p>
<ul>
<li>
<p>obese</p>
</li>
<li>
<p>recently commenced on diuretics</p>
</li>
<li>
<p>sudden onset (“flash”) pulmonary oedema</p>
</li>
</ul>
</li>
<li>
<p>if diagnosis likely from clinical and other tests:</p>
<ul>
<li>
<p>ecg</p>
</li>
<li>
<p>cxr</p>
</li>
<li>
<p>do <strong>not</strong> require BNP</p>
</li>
</ul>
</li>
</ul>
<h4 id="ecg">ECG</h4>
<ul>
<li>
<p>long term left ventricular dysfunction</p>
<ul>
<li>
<p>LA enlargement</p>
</li>
<li>
<p>LV hypertrophy</p>
</li>
</ul>
</li>
<li>
<p>normal ECG usually rulse out heart failure</p>
</li>
<li>
<p>assess other cardiac pathology</p>
</li>
</ul>
<h4 id="cxr">CXR</h4>
<ul>
<li>
<p>most useful in apatient who is acutely unwell with pulmonary oedema</p>
</li>
<li>
<p>may help differentiate from pulmonary causes of SOB</p>
</li>
</ul>
<h3 id="classification">Classification</h3>
<ul>
<li>
<p>worsening prognosis as move down classes;</p>
</li>
<li>
<p>NYHA</p>
</li>
<li>
<p>Class I:</p>
<ul>
<li>asymptomatic</li>
</ul>
</li>
<li>
<p>Class 2:</p>
<ul>
<li>
<p>mild symptoms</p>
</li>
<li>
<p>comfortable at rest</p>
</li>
<li>
<p>dyspnoea, fatigue, palpitations with ordinary physical activity</p>
</li>
</ul>
</li>
<li>
<p>Class 3:</p>
<ul>
<li>
<p>moderate symptoms</p>
</li>
<li>
<p>comfortable at rest</p>
</li>
<li>
<p>develops dyspnoea, fatigue, palpitations with less than ordinary phsycial activity</p>
</li>
</ul>
</li>
<li>
<p>class 4:</p>
<ul>
<li>
<p>severe symptoms</p>
<ul>
<li>unable to do any psycal activity</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="management">Management</h3>
<blockquote>
<p>goal = </p>
<ul>
<li>
<p>improve symptoms and signs</p>
</li>
<li>
<p>decrease hospital admission</p>
</li>
<li>
<p>improve longevity</p>
</li>
</ul>
</blockquote>
<h4 id="hf-ref">HF-REF</h4>
<ul>
<li>
<p><strong>diuretic</strong></p>
<ul>
<li>
<p>reduce fluid overload to improve patient’s symptoms</p>
</li>
<li>
<p>no evidence improve mortality</p>
</li>
<li>
<p><strong>loop</strong> diurectic</p>
<ul>
<li>
<p>more effective</p>
</li>
<li>
<p><strong>frusemide </strong>20-40mg daily</p>
</li>
<li>
<p>improvement and weight loss of 1.0kg/day</p>
</li>
<li>
<p><strong>bumetanide</strong> alternative who don’t respond</p>
<ul>
<li>
<p>0.5-1mg/day</p>
</li>
<li>
<p>max = 5mg/day</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>too little;</p>
<ul>
<li>
<p>blunt repsonse to ACEi</p>
</li>
<li>
<p>increase risk of decomensation when Bblocker introduced</p>
</li>
</ul>
</li>
<li>
<p>too much;</p>
<ul>
<li>
<p>increase risk of hypotension and rnal impairment</p>
<ul>
<li>especially when ACEi started</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>add <strong>ACEi</strong> and <strong>beta-blocker</strong></p>
<ul>
<li>
<p>improve both morbidity and mortality </p>
</li>
<li>
<p>ACEi</p>
<ul>
<li>
<p>reduce symptoms</p>
</li>
<li>
<p>assis wtih LV remodelling</p>
</li>
<li>
<p>any medicine from ACEi class</p>
</li>
<li>
<p>if hypotension going to occur - will occur @ low doses; increasing dose wont’ make a difference</p>
</li>
<li>
<p>acceptable:</p>
<ul>
<li>
<p>K \&lt;5.5</p>
</li>
<li>
<p>eFGR \&lt;50% increase in baseline</p>
<ul>
<li>if Cr >30% then change dose in CKD</li>
</ul>
</li>
</ul>
</li>
<li>
<p>if elevation:</p>
<ul>
<li>
<p>reduce dose of diuretic, stop nephrotoxic</p>
<ul>
<li>
<p>if remain raised</p>
<ul>
<li>
<p>halve dose of ACEi</p>
</li>
<li>
<p>check in 2 weeks</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>beta-blocker</p>
<ul>
<li>
<p>improve ventricular function</p>
<ul>
<li>markedly improve ejection fraction</li>
</ul>
</li>
<li>
<p>no clear evidecne that any one more superior</p>
<ul>
<li>
<p>bisoprolol</p>
<ul>
<li>
<p>more cardioselective</p>
</li>
<li>
<p>reduces hr more than other betablockers</p>
</li>
<li>
<p>1.25mg OD gradually increasing </p>
<ul>
<li>aim for maintenance dose of 10mg od</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>start at low dose</p>
<ul>
<li>‘go slow, aim high’</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Add <strong>spironolactone</strong></p>
<ul>
<li>
<p>aldoseterone receptor antagonist</p>
</li>
<li>
<p>remain symptomatic or EF\&lt;35%</p>
</li>
<li>
<p>reduce both morbidity and mortality</p>
</li>
<li>
<p>used in caution with impiared renal function and may cause hyperkalaemia</p>
</li>
</ul>
</li>
<li>
<p><strong>Digoxin</strong></p>
<ul>
<li>
<p>slow ventricular rate</p>
<ul>
<li>
<p>improve symptoms</p>
<ul>
<li>symptomatic HF and AF</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Use CHA2DS2 - VASc</p>
</li>
<li>
<p>digoxin didn’t improve survival</p>
<ul>
<li>
<p>64% improvement symptoms</p>
<ul>
<li>NNT 9</li>
</ul>
</li>
<li>
<p>23% reduction in hospitalisation </p>
</li>
<li>
<p>DIG trial</p>
</li>
</ul>
</li>
<li>
<p>toxicity increase by hypokalaemia</p>
</li>
</ul>
</li>
<li>
<p><strong>nitrates</strong></p>
<ul>
<li>
<p>V-HEFT</p>
<ul>
<li>improve mortality in chronic heart failure</li>
</ul>
</li>
</ul>
</li>
</ul>
<h4 id="hf-pef">HF-PEF</h4>
<ul>
<li>
<p>evidence limited</p>
</li>
<li>
<p>should usually be referred to cardiologist for initial management</p>
</li>
<li>
<p>usually more brittle</p>
<ul>
<li>require careful control of fluid balance</li>
</ul>
</li>
<li>
<p><strong>beta blockers</strong></p>
<ul>
<li>
<p>prolonging diastole</p>
</li>
<li>
<p>rate limiting CCB can be used as an alternative</p>
<ul>
<li>
<p>may improve symptoms and exercsie tolerance</p>
</li>
<li>
<p>NOT HF-REF</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>ACEi</strong></p>
</li>
<li>
<p><strong>Digoxin</strong></p>
</li>
</ul>
<h4 id="non-pharmacological">Non-pharmacological</h4>
<ul>
<li>
<p>weight themselves daily</p>
<ul>
<li>establish “dry weight”</li>
</ul>
</li>
<li>
<p>Participate in regular exercise</p>
</li>
<li>
<p>Avoid excessive salt and etoh</p>
</li>
<li>
<p>monitor fluid intake</p>
<ul>
<li>1.5-2L/day restrict</li>
</ul>
</li>
<li>
<p>maximise adherence to medicines</p>
</li>
<li>
<p>annyal influenza vaccination</p>
</li>
</ul>
<h4 id="referral">Referral</h4>
<ul>
<li>
<p>valvular heart disease</p>
</li>
<li>
<p>heart failure and syncope</p>
<ul>
<li>PPM</li>
</ul>
</li>
<li>
<p>HF and LBBB and wide QRS</p>
<ul>
<li>
<p>associated with dyssyncrony</p>
</li>
<li>
<p>Caridac resynchronisation therapy/biventricular pacing may be indicated</p>
</li>
</ul>
</li>
<li>
<p>history of cardiac arrest of VT</p>
</li>
</ul>
<h4 id="left-ventricular-systolic-dysfunction">Left ventricular systolic dysfunction</h4>
<ul>
<li>
<p>LVEF \&lt;45%</p>
</li>
<li>
<p>patient education</p>
</li>
<li>
<p>self managmenet</p>
</li>
<li>
<p>non pharmacological</p>
</li>
<li>
<p>pharmacotherapy</p>
<ul>
<li>
<p>ACEi / ARB</p>
</li>
<li>
<p>Diuretics</p>
</li>
<li>
<p>beta- blockers</p>
</li>
<li>
<p>spironolactone</p>
</li>
</ul>
</li>
<li>
<p>Device</p>
<ul>
<li>
<p>cardiac resynchronisation therapy</p>
</li>
<li>
<p>implantable cardioverter defibrillator</p>
</li>
</ul>
</li>
<li>
<p>Additional pharmacotherpy</p>
<ul>
<li>
<p>Digoxin</p>
</li>
<li>
<p>nitrate</p>
</li>
</ul>
</li>
<li>
<p>management of co-existing AF</p>
</li>
</ul>
<p>- </p>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
